Price Chart

Profile

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
URL https://www.pfizer.com
Investor Relations URL https://investors.pfizer.com
HQ State/Province New York
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release May. 02, 2024 (est.)
Last Earnings Release Jan. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jan. 25, 2024

Profile

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
URL https://www.pfizer.com
Investor Relations URL https://investors.pfizer.com
HQ State/Province New York
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release May. 02, 2024 (est.)
Last Earnings Release Jan. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jan. 25, 2024